Company
InterVene
Reshaping the interventional treatment of venous in-stent restenosis and native vessel obstructions.
Also known as InterVene, Inc.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Legal name
- InterVene, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
InterVene, Inc. is a trailblazing medical device company focused on bringing innovative technologies to treat the persistent challenges related to venous in-stent restenosis (ISR) and residual thrombotic venous obstructions and occlusions that current therapies fail to address.
Funding snapshot
- Total raised
- $11.1MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $1.5M2023-02-21
Funding rounds
- Round, 2023
- $1.5M2023-02-21, SEC form D sold, 6 investors
- Round, 2017
- $2.2M2017-05-11, SEC form D sold, 17 investors
- Round, 2015
- $5.9M2015-03-16, SEC form D sold, 52 investors
Products
- Hardware
- Recana Thrombectomy Catheter System
Loading relationship preview